Meridian Bioscience Earlier Reported Q4 EPS $0.13 Beats $0.09 Estimate, Sales $50.846M Beat $50.59M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.09 by 44.44 percent. This is a 35 percent decrease over earnings of $0.2 per share from the

Benzinga · 11/07/2019 14:31

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.09 by 44.44 percent. This is a 35 percent decrease over earnings of $0.2 per share from the same period last year. The company reported quarterly sales of $50.846 million which beat the analyst consensus estimate of $50.59 million by 0.51 percent. This is a 4.24 percent decrease over sales of $53.1 million the same period last year.